Literature DB >> 20640797

On the metal ion (Zn(2+), Cu(2+)) coordination with beta-amyloid peptide: DFT computational study.

T Marino1, N Russo, M Toscano, M Pavelka.   

Abstract

As is widely accepted, the crucial event of the progress of Alzheimer's disease is the formation of extracellular neurotoxic amyloid plaques, consisting mainly of 40 or 42 amino acid residues, in the brain. Zinc and copper metal ions are involved in this process, since they enhance the amyloid beta aggregation and are incorporated into plaques. In this paper we have analyzed theoretically the energetics implied in the formation of some complexes of both cations, adopting a number of models that take into account various coordination environments. The aim was to determine which among the coordination patterns examined is the favoured one in order to give better insight in the controversy concerning the metal binding site of amyloid beta peptide.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20640797     DOI: 10.1007/s12539-010-0086-x

Source DB:  PubMed          Journal:  Interdiscip Sci        ISSN: 1867-1462            Impact factor:   2.233


  6 in total

1.  Calculating the geometry and Raman spectrum of physiological bis(L-histidinato)copper(II): an assessment of DFT functionals for aqueous and isolated systems.

Authors:  Jasmina Sabolović; Michael Ramek; Marijana Marković
Journal:  J Mol Model       Date:  2017-09-26       Impact factor: 1.810

2.  Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

Authors:  Willam T Wang; Breeya A Tailor; David S Cohen; Xudong Huang
Journal:  EC Pharmacol Toxicol       Date:  2019-06-21

Review 3.  Role of metal dyshomeostasis in Alzheimer's disease.

Authors:  David J Bonda; Hyoung-gon Lee; Jeffrey A Blair; Xiongwei Zhu; George Perry; Mark A Smith
Journal:  Metallomics       Date:  2011-02-07       Impact factor: 4.526

4.  A computational study of metal ions interaction with amyloid-β 1-42 peptide structure in hyperpyrexia: Implications for Alzheimer disease.

Authors:  Cosmin Stefan Mocanu; Laura Darie-Ion; Brindusa Alina Petre; Vasile Robert Gradinaru; Gabi Drochioiu
Journal:  J King Saud Univ Sci       Date:  2022-06-28

5.  Surface-engineered nanoliposomes by chelating ligands for modulating the neurotoxicity associated with β-amyloid aggregates of Alzheimer's disease.

Authors:  Maluta S Mufamadi; Yahya E Choonara; Pradeep Kumar; Girish Modi; Dinesh Naidoo; Valence M K Ndesendo; Lisa C du Toit; Sunny E Iyuke; Viness Pillay
Journal:  Pharm Res       Date:  2012-05-15       Impact factor: 4.200

Review 6.  Amyloid Oligomers: A Joint Experimental/Computational Perspective on Alzheimer's Disease, Parkinson's Disease, Type II Diabetes, and Amyotrophic Lateral Sclerosis.

Authors:  Phuong H Nguyen; Ayyalusamy Ramamoorthy; Bikash R Sahoo; Jie Zheng; Peter Faller; John E Straub; Laura Dominguez; Joan-Emma Shea; Nikolay V Dokholyan; Alfonso De Simone; Buyong Ma; Ruth Nussinov; Saeed Najafi; Son Tung Ngo; Antoine Loquet; Mara Chiricotto; Pritam Ganguly; James McCarty; Mai Suan Li; Carol Hall; Yiming Wang; Yifat Miller; Simone Melchionna; Birgit Habenstein; Stepan Timr; Jiaxing Chen; Brianna Hnath; Birgit Strodel; Rakez Kayed; Sylvain Lesné; Guanghong Wei; Fabio Sterpone; Andrew J Doig; Philippe Derreumaux
Journal:  Chem Rev       Date:  2021-02-05       Impact factor: 60.622

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.